Le Lézard
Classified in: Health, Business
Subjects: TNM, CON, SBS

Quest Products, Inc. Merges with OraHealth Corporation Inc, Makers of OraCoat®, The Highly Trusted Oral Care Brand for Dry Mouth


PLEASANT PRAIRE, Wis., Jan. 14, 2019 /PRNewswire/ -- Quest Products, Inc. (Quest) today announced its merger with OraHealth Corporation, Inc. (OraHealth). Quest is a portfolio company of Promus Equity Partners (Promus).

With this merger, Quest will add the OraCoat® brand of oral care products and its flagship product, Xylimelts® for Dry Mouth. Xylimelts® employs patented technology backed by research and medical science to safely prevent dry mouth while the user sleeps via all-natural, non-acidic oral-adhering discs that slowly release safe ingredients.

 "We are proud to add OraCoat® and its line of oral care products to our portfolio of category-leading brands including Clinere®, Alocane® and ProVent®," Don Ryan, CEO of Quest commented. "We are excited to partner with OraHealth founder Jeff Haley and his team to expand the distribution of the blockbuster Xylimelt® product domestically and internationally."

Jeff Haley, founder and President of OraHealth commented, "Together, we will endeavor to increase consumer awareness of this revolutionary treatment for dry mouth and introduce innovative new products using our patent protected technology."

Cascadia Capital advised OraHealth in the transaction, while Carney Badley Spellman provided legal representation. Reinhart Boerner Van Deuren provided legal counsel to Quest.

Avante Mezzanine Partners provided mezzanine debt and participated in the equity investment, while MB Financial provided a senior credit facility. Terms of the investment were not disclosed.

About OraHealth Corporation
OraHealth Corporation is the market leader in all-natural and non-acidic oral-adhering discs based upon its patented technology with slowly release ingredients in the mouth and are safe for use while sleeping. The OraCoat® brand represents a family of products to solve oral care problems by coating the mouth with safe ingredients that become effective when they are slowly released and its flagship product is XyliMelts® for Dry Mouth. OraCoat®'s innovative oral care solutions are backed by research based on medical science to ensure optimum performance and user safety.

About Quest Products
Quest Products Inc. is a multifaceted consumer packaged goods company that manufactures and manages wholly owned brands, distributes national brands, sells to retail and online stores, provides drop-ship services, and manages retail websites. Quest seeks to bring innovative, quality products to customers' doors or retail stores. Quest brands include Clinere®, Alocane®, ProVent®, AlcoHawk®, CopperFixx® and Blue Guard®. Find out more at www.questproductsinc.com.

About Promus Equity Partners
Promus Equity Partners is a private equity firm affiliated with Promus Holdings, a Chicago-based multi-family office. Promus targets healthy lower-middle-market companies with a strong value proposition and outstanding growth prospects. Promus team members are proven investors with wide-ranging experience over numerous economic cycles in a variety of industries. For more information about Promus Equity Partners, contact Steve Brown at sbrown@promusequity.com or Sarah Wuellner at swuellner@promusequity.com.

Media Contact: Mark McGreevy, Quest Products, Inc., 262-925-0987, 207545@email4pr.com 

SOURCE Quest Products, Inc


These press releases may also interest you

at 03:11
AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the January - June 2019 is now available on the company's website: https://www.alzecurepharma.se/sv/section/investerare/finansiella-rapporter/ Financial...

at 03:05
August 22, 2019 Philips IntelliSite Pathology Solution adopted by Taiwan's leading academic medical and teaching center Taipei Veterans General HospitalPhilips IntelliSite Pathology Solution cleared for routine primary diagnostic use in Taiwan ...

at 03:00
TECH5 has successfully integrated MOSIP®1 with its T5-ABIS2 platform and Biometric SDKs for finger, iris and face recognition. TECH-5 presented a tested and ready-to-use solution with implemented biometrics to the Executive Committee and...

at 03:00
Daiichi Sankyo Company,...

at 03:00
- Data presentations from ENTRUST-AF PCI and ETNA-AF add to the growing body of scientific evidence from the Edoxaban Clinical Research Programme - First-time presentation of ENTRUST-AF PCI clincial results assessing edoxaban in atrial fibrillation...

at 02:55
Cantargia AB's ("Cantargia") half year report for the period January until June 2019 is now available on the company's web page www.cantargia.com/en/investors/financial-reports. Significant events in the second quarter  In May 2019, Cantargia AB and...



News published on 14 january 2019 at 08:31 and distributed by: